Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter S. Kim currently holds 16,000 shares of Entrada Therapeutics, Inc. (TRDA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter S. Kim has been a net seller of TRDA stock. They have purchased $642.0K and sold $19.1M worth of shares.
Peter S. Kim's most recent insider trade was on Jun 13, 2024, when they sold 16,000 shares at $0.00 per share.
Peter S. Kim serves as Executive at Entrada Therapeutics, Inc. (TRDA). They have executed 44 insider transactions totaling $19.8M over their tenure at the company.
Peter S. Kim holds the position of Executive at Entrada Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Peter S. Kim has shown a selling trading pattern, with $642.0K in total purchases and $19.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peter S. Kim was on Nov 5, 2012, when they sold $19.1M worth of MRK shares. This transaction involved 420,000 shares at $45.50 per share.
Peter S. Kim currently owns 16,000 shares of Entrada Therapeutics, Inc. (TRDA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter S. Kim's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter S. Kim has 44 Form 4 filings on record as an insider at Entrada Therapeutics, Inc..
Set alerts for Peter S. Kim and 40,000+ other insiders.